A. Hansen, P. E. Lipsky, and T. Dörner, B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue, Arthritis Res Ther, vol.9, p.218, 2007.

P. Brito-zerón, S. Retamozo, M. Gandía, M. Akasbi, M. Pérez-de-lis et al., Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes, J Autoimmun, vol.39, pp.43-51, 2012.

M. Bombardieri, F. Barone, D. Lucchesi, S. Nayar, W. B. Van-den-berg et al., Inducible tertiary lymphoid structures, autoimmunity and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice, J Immunol, vol.189, pp.3767-76, 2012.

S. Salomonsson, M. V. Jonsson, K. Skarstein, K. A. Brokstad, P. Hjelmström et al., Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome, Arthritis Rheum, vol.48, pp.3187-201, 2003.

C. P. Mavragani, A. G. Tzioufas, and H. M. Moutsopoulos, Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects, Int Arch Allergy Immunol, vol.123, pp.46-57, 2000.

P. Wei, C. Li, L. Qiang, J. He, Z. Li et al., Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren's syndrome. Med Oral Patol Oral Cir Bucal, vol.20, 2015.

R. Patel and A. Shahane, The epidemiology of Sjögren's syndrome, Clin Epidemiol, vol.6, pp.247-255, 2014.

A. Igoe and R. H. Scofield, Autoimmunity and infection in Sjögren's syndrome, Curr Opin Rheumatol, vol.25, pp.480-487, 2013.

A. H. Draborg, K. Duus, and G. Houen, Epstein-Barr virus in systemic autoimmune diseases, J Immunol Res, p.535738, 2013.

R. D. Kieff, D. M. Knipe, P. M. Howley, . Fields, and . Virology, , 2001.

G. J. Babcock, D. Hochberg, and A. D. Thorley-lawson, The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell, Immunity, vol.13, pp.497-506, 2000.

D. A. Thorley-lawson and A. Gross, Persistence of the epstein-barr virus and the origins of associated lymphomas, N Engl J Med, vol.350, pp.1328-1365, 2004.

A. Tabaa, Y. Tuaillon, E. Bollore, K. Foulongne, V. Petitjean et al., Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells, Blood, vol.113, pp.604-611, 2009.

C. Croia, E. Astorri, W. Murray-brown, A. Willis, K. A. Brokstad et al., Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome, Arthritis Rheumatol, vol.66, pp.2545-2557, 2014.

X. Mariette, J. Gozlan, D. Clerc, M. Bisson, and F. Morinet, Detection of epstein-barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome, Am J Med, vol.90, pp.286-94, 1991.

I. Saito, B. Servenius, T. Compton, and R. I. Fox, Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome, J Exp Med, vol.169, pp.2191-2199, 1989.

A. Lossius, J. N. Johansen, Ø. Torkildsen, F. Vartdal, and T. Holmøy, Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis-association and causation, Viruses, vol.4, pp.3701-3731, 2012.

K. H. Costenbader and E. W. Karlson, Epstein-Barr virus and rheumatoid arthritis: is there a link?, Arthritis Res Ther, vol.8, p.204, 2006.

J. A. James, J. M. Robertson, . Lupus, and . Epstein-barr, Curr Opin Rheumatol, vol.24, pp.383-391, 2012.

G. Nocturne, D. Cornec, R. Seror, and M. X. , Use of Biologics in Sjögren's Syndrome, Rheum Dis Clin North Am, vol.42, pp.407-424, 2016.

S. Seo, J. Y. Hong, S. Yoon, C. Yoo, J. H. Park et al., Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era, Oncotarget, vol.7, pp.76934-76943, 2016.

J. E. Gottenberg, R. Seror, C. Miceli-richard, J. Benessiano, V. Devauchelle-pensec et al., Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort, PLoS ONE, vol.8, p.59868, 2013.

R. Seror, S. J. Bowman, P. Brito-zeron, E. Theander, H. Bootsma et al., EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide, RMD Open, vol.1, p.22, 2015.

X. Mariette and J. E. Gottenberg, Pathogenesis of Sjögren's syndrome and therapeutic consequences, Curr Opin Rheumatol, vol.22, pp.471-477, 2010.

J. A. Katzmann, R. J. Clark, R. S. Abraham, S. Bryant, J. F. Lymp et al., Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains, Clin Chem, vol.48, pp.1437-1444, 2002.

N. Venhoff, N. M. Effelsberg, U. Salzer, K. Warnatz, H. H. Peter et al., Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides, PLoS ONE, vol.7, p.37626, 2012.

A. H. Draborg, M. C. Lydolph, M. Westergaard, S. Olesen-larsen, C. T. Nielsen et al., Elevated concentrations of serum immunoglobulin free light chains in systemic Lupus Erythematosus patients in relation to disease activity, inflammatory status, B Cell Activity and Epstein-Barr virus antibodies, PLoS ONE, vol.10, p.138753, 2015.

J. Zuccolo, T. L. Unruh, and J. P. Deans, Efficient isolation of highly purified tonsil B lymphocytes using RosetteSep with allogeneic human red blood cells, BMC Immunol, vol.10, p.30, 2009.

D. E. Ouedraogo, K. Bollore, J. Viljoen, V. Foulongne, J. Reynes et al., Comparison of EBV DNA viral load in whole blood, plasma, B-cells and Bcell culture supernatant, J Med Virol, vol.86, pp.851-856, 2014.

A. Sanosyan, &. Fayd, A. De-maudave, K. Bollore, V. Zimmermann et al., The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification, PLoS ONE, vol.12, p.183856, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01890162

A. F. Orozco, C. J. Jorgez, C. Horne, D. A. Marquez-do, M. R. Chapman et al., Membrane protected apoptotic trophoblast microparticles contain nucleic acids, Am J Pathol, vol.173, pp.1595-1608, 2008.

R. K. Saiki, D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi et al., Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase, Science, vol.239, pp.487-491, 1988.

F. Franceschini, I. Cavazzana, L. Andreoli, and A. Tincani, The 2016 classification criteria for primary Sjogren's syndrome: what's new?, BMC Med, vol.15, p.69, 2017.

I. Toda, M. Ono, H. Fujishima, and K. Tsubota, Sjögren's syndrome (SS) and Epstein-Barr virus (EBV) reactivation, Ocul Immunol Inflamm, vol.2, pp.101-109, 1994.

N. Miyasaka, K. Yamaoka, M. Tateishi, K. Nishioka, and K. Yamamoto, Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjögren's syndrome, J Autoimmun, vol.2, pp.427-432, 1989.

N. Inoue, S. Harada, N. Miyasaka, A. Oya, and K. Yanagi, Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjögren's syndrome and with rheumatoid arthritis, J Infect Dis, vol.164, pp.22-28, 1991.

S. G. Pasoto, R. R. Natalino, H. P. Chakkour, V. Viana, C. Bueno et al., EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?, Rheumatol Int, vol.33, pp.1149-1157, 2013.

S. Kivity, M. T. Arango, M. Ehrenfeld, O. Tehori, Y. Shoenfeld et al., Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review, J Autoimmun, vol.51, pp.17-22, 2014.

R. D. Hess, Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years, J Clin Microbiol, vol.42, pp.3381-3388, 2004.

D. K. Paramita, J. Fachiroh, W. T. Artama, E. Van-benthem, S. M. Haryana et al., Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma, J Med Virol, vol.79, pp.1710-1721, 2007.

M. De-paschale and P. Clerici, Serological diagnosis of Epstein-Barr virus infection: Problems and solutions, World J Virol, vol.1, pp.31-43, 2012.

D. Cornec, A. Saraux, V. Devauchelle-pensec, C. Clodic, and J. O. Pers, The future of B cell-targeted therapies in Sjögren's syndrome, Immunotherapy, vol.5, pp.639-646, 2013.

D. Vita, S. Quartuccio, L. Seror, R. Salvin, S. Ravaud et al., Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study, Rheumatology, vol.54, pp.2249-56, 2015.

H. Letaief, C. Lukas, T. Barnetche, C. Gaujoux-viala, B. Combe et al., Efficacy and safety of biological DMARDs modulating B cells in primary Sjögren's syndrome: systematic review and meta-analysis, Joint Bone Spine, vol.85, pp.15-22, 2017.

A. Tabaa, Y. Tuaillon, E. Jeziorski, E. Ouedraogo, D. E. Bolloré et al., B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis, J Clin Virol Off Publ Pan Am Soc Clin Virol, vol.52, pp.33-37, 2011.

M. Tateishi, I. Saito, K. Yamamoto, and N. Miyasaka, Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis, Arthritis Rheum, vol.36, pp.827-835, 1993.

C. E. Willoughby, K. Baker, S. B. Kaye, P. Carey, O. Donnell et al., Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection, J Med Virol, vol.68, pp.378-383, 2002.

S. Perrot, V. Calvez, J. P. Escande, N. Dupin, and A. G. Marcelin, Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjögren's syndrome using degenerated consensus PCR primers, J Clin Virol Off Publ Pan Am Soc Clin Virol, vol.28, pp.165-168, 2003.

B. Serafini, B. Rosicarelli, D. Franciotta, R. Magliozzi, R. Reynolds et al., Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain, J Exp Med, vol.204, pp.2899-912, 2007.

J. W. Lindsey, L. M. Hatfield, and T. Vu, Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis, Eur J Neurol Off J Eur Fed Neurol Soc, vol.17, pp.1263-1272, 2010.

J. W. Lindsey, L. M. Hatfield, M. P. Crawford, and S. Patel, Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis, Mult Scler, vol.15, pp.153-158, 2009.

V. Hadinoto, M. Shapiro, C. C. Sun, and D. A. Thorley-lawson, The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output, PLoS Pathog, vol.5, p.100049, 2009.